ライフサイエンスコーパス: Gd

1 Gd-Hyd MRI had the highest accuracy (24 of 26, 92%; 95%

2 Gd-IHEP-7 and Gd-IHEP-8 show excellent activity toward s

3 Gd-MSN also can be taken up into cancer cells and locali

4 Gd-TREN-MAM is highly selective for phosphate over other

5 If 1-Gd is dissolved in THF instead of Et(2)O under N(2), the

6 The reaction of 1-Gd with dinitrogen forms a complex with the same composi

7 With 13% Gd in Fe there is evidence indicating the presence of a

8 (36)Cl and the alpha-emitters (154)Dy, (148)Gd, (150)Gd, and (146)Sm from Ta targets irradiated with

9 ons showed a satisfactory agreement for (148)Gd (less than within a factor two), while measured (154)

10 work presents the determination of the (148)Gd and (154)Dy content in Pb targets irradiated by 220-2

11 nd the alpha-emitters (154)Dy, (148)Gd, (150)Gd, and (146)Sm from Ta targets irradiated with protons

12 as a poison in early reactors(7,8), and (157)Gd (2.5 x 10(5) barns), which is used as a detector mate

13 ra-arterial infusion of gadolinium 160 ((160)Gd)-labeled anti-human leukocyte antigen-DR isotope (HLA

14 Results T1-weighted MRI with (160)Gd-labeled antibodies revealed localized peritumoral rin

15 (N(2))(3-) complex [K(crypt)][(THF)(R(2)N)(2)Gd](2)[mu-eta(2):eta(2)-N(2)], 9-Gd, is observed.

16 a-amide complex, [K(THF)(6)]{[(THF)(R(2)N)(2)Gd][mu-eta(2):eta(2)-N(2)][Gd(NR(2))(3)]}, 8-Gd, synthes

17 ]{[(THF)(R(2)N)(2)Gd][mu-eta(2):eta(2)-N(2)][Gd(NR(2))(3)]}, 8-Gd, synthesized at -196 degrees C.

18 es show that I-Mg(3)Zn(6)Gd phase and W-Mg(3)Gd(2)Zn(3) phase are crushed into small particles during

19 n the same crystal, [K(crypt)](2){[(R(2)N)(3)Gd](2)[mu-eta(x):eta(x)-N(2)]} (x = 1 and 2), 5-Gd.

20 binding modes: [K(2)(18-c-6)(3)]{[(R(2)N)(3)Gd](2)[mu-eta(x):eta(x)-N(2)]} (x = 1, 2), 6-Gd.

21 nt combinations of rare earth ions (RE(3+) = Gd, Eu, Yb, Tm) to achieve a synergy among their magneti

22 metal ions (RE(3+) = Y(3+), Sm(3+), Eu(3+), Gd(3+), Tb(3+), Dy(3+), Ho(3+), Er(3+), Tm(3+), Yb(3+))

23 ants (Al(3+), Co(3+), Sc(3+), In(3+), Y(3+), Gd(3+) and La(3+)) were considered to create additional

24 Similarly, the 18-c-6 Gd(II) complex, 3-Gd, generates a product with both binding modes: [K(2)(1

25 , and 0.74 (95% CI: 0.63, 0.86) for EP-3533, Gd-Hyd, MR elastography, and native T1, respectively.

26 (2)[mu-eta(x):eta(x)-N(2)]} (x = 1 and 2), 5-Gd.

27 reduced dinitrogen complexes, 2-Tb, 4-Tb, 5-Gd, and 6-Gd, have three ancillary amide ligands per met

28 When 5-Gd and 6-Gd are warmed above -15 degrees C, they reform

29 ard core-shell architecture of beta-NaY(0.58)Gd(0.2)Yb(0.2)Er(0.02)F(4) (core) @NaY(0.8)Gd(0.2)F(4) (

30 Similarly, the 18-c-6 Gd(II) complex, 3-Gd, generates a product with both bind

31 crostructural analyses show that I-Mg(3)Zn(6)Gd phase and W-Mg(3)Gd(2)Zn(3) phase are crushed into sm

32 gthened with quasicrystal phase (I-Mg(3)Zn(6)Gd phase) is prepared through hot extrusion and subseque

33 Gd](2)[mu-eta(x):eta(x)-N(2)]} (x = 1, 2), 6-Gd.

34 When 5-Gd and 6-Gd are warmed above -15 degrees C, they reform Gd(II) co

35 initrogen complexes, 2-Tb, 4-Tb, 5-Gd, and 6-Gd, have three ancillary amide ligands per metal.

36 coercivity falls by a factor of ten with 8% Gd.

37 x)Er(x)Gd(0.2)F(4) (interior shell) @NaY(0.8)Gd(0.2)F(4) (exterior shell), where sensitizer and emitt

38 8)Gd(0.2)Yb(0.2)Er(0.02)F(4) (core) @NaY(0.8)Gd(0.2)F(4) (shell), with sensitizer and emitter ions co

39 Gd][mu-eta(2):eta(2)-N(2)][Gd(NR(2))(3)]}, 8-Gd, synthesized at -196 degrees C.

40 F)(R(2)N)(2)Gd](2)[mu-eta(2):eta(2)-N(2)], 9-Gd, is observed.

41 To address a perceived need for a Gd-free contrast agent with pharmacokinetic and imaging

42 through an active staining protocol using a Gd chelate.

43 sibility of using W-band spectroscopy with a Gd(III) label for investigation of the structural dynami

44 e in r(1) relaxivity over gadopentetic acid (Gd-DTPA) and have better X-ray absorption ability than r

45 aramagnetic contrast such as gadoteric acid (Gd-DOTA) administration into cerebrospinal fluid (CSF) r

46 ybenzyl-diethylenetriamine-pentaacetic acid (Gd-EOB-DTPA) with dynamic contrast-enhanced MR imaging (

47 he diagnostic performance of gadoxetic acid-(Gd-EOB) enhanced liver MRI and contrast-enhanced MDCT in

48 In addition, Gd deposition in the human brain has been reported follo

49 bing extravasation of the MRI contrast agent Gd-DTPA was significantly increased in both the sonicate

50 al concentration of two MRI contrast agents (Gd-BOPTA and Dy-DOTA-azide) in a mouse glioma model.

51 baseline in T2 (18.4% vs 32.4%, p<0.001) and Gd+ T1 (-72.3% vs 4.9%, p=0.001) lesion volumes and ARBA

52 Gd-IHEP-7 and Gd-IHEP-8 show excellent activity toward solar-driven ni

53 ion (Prato reaction) of Y(3)N@I(h)-C(80) and Gd(3)N@I(h)-C(80) with an excess of N-ethylglycine and f

54 tetra-isomers for both Y(3)N@I(h)-C(80) and Gd(3)N@I(h)-C(80).

55 Our findings also suggest that Av and Gd MoFePs evolved with specific preferences for Ser and

56 to incorporation of Gd ions, Gd chelates and Gd/other imaging probes in the theranostic agents.

57 MATERIAL/73 patients underwent DCECT and Gd-EOB-DTPA-3T-MR.

58 Gd-P showed the highest activities, Gl-L and Gd-L exhibited comparable 1,1-diphenyl-2-picrylhydrazyl

59 atterns of the peptide fragments in Gl-L and Gd-L were similar, but more fragments and higher molecul

60 two water soluble protein samples (Gl-L and Gd-L) isolated in a lab scale from glandless and common

61 of linoleic acid autoxidation than Gl-L and Gd-L.

62 r with a (6)LiF neutron conversion layer and Gd-doped GaN detector are compared with intrinsic GaN de

63 ) to >1 mg day(-1) (e.g., Zn, Sc, Y, Nb, and Gd) and >1 g day(-1) (e.g., for P, Fe, and S).

64 l labeling approach, employing nitroxide and Gd(III) spin labels, in conjunction with Q-band and W-ba

65 (Papio anubis; n = 4) by using Mn-PyC3A and Gd-DTPA.

66 lcium uniporter inhibitors Ruthenium Red and Gd(3+), as well as to the Arabidopsis protein MICU, a re

67 g (affected by choice of valence state), and Gd.

68 lesions (6 months onward), changes in T2 and Gd+ T1 lesion volumes and annualised rate of brain atrop

69 mposition Gd(x)Co(100-x), Gd(x)Fe(100-x) and Gd(x)(Co(50)Fe(50))(100-x) were prepared by magnetron sp

70 to the interdiffusion of Y from the YIG and Gd from the substrate, an addition magnetic layer is for

71 ared, coencapsulating doxorubicin (dox) and [Gd(HPDO3A)(H2O)], and injected in tumor-bearing rats bef

72 iezo2 small interfering RNA and antagonists (Gd(3+) and D-GsMTx4).

73 etic [Gd(2)C](2+).2e(-) to antiferromagnetic Gd(2)CCl caused by attenuating interatomic exchange inte

74 pin alignments within the antiferromagnetic [Gd(2)C](2+) lattice framework.

75 nhancement of the previous state-of-the-art [Gd(dota)(H(2)O)](-) at 9.4 T and 100 K.

76 ent or diminished in other f(7) ions such as Gd(III) or Cm(III).

77 ng (RIXS) experiments on Gd x Sc3-x N@C80 at Gd N 4,5-edges to directly study the electronic structur

78 ter magnetic resonance imaging (MRI), before Gd can deposit in the body and cause long-term toxicity.

79 ng applications, we introduced bioresponsive Gd(III)-based magnetic resonance contrast agents (GBCAs)

80 We propose a new strategy to reduce blood Gd content that facilitates whole body removal of Gd usi

81 pregnant mice after administration of b-BSA-Gd-DTPA and analyzed using a new sub-voxel biophysical s

82 nd recycling associated with the large b-BSA-Gd-DTPA conjugate.

83 ansporters with free biotin suppressed b-BSA-Gd-DTPA uptake.

84 gation of biotinylated contrast agent (b-BSA-Gd-DTPA).

85 ived from the {111} and {100} planes of bulk Gd(2)O(3), respectively.

86 sequential deglycosylation to remove all but Gd O-glycans from the HR.

87 ondary neutrons are produced and absorbed by Gd in the tumor providing potential enhanced localized d

88 ther elements was between 70 to 100% for Cd, Gd, Mg, Mn, U, and Yb, 50 to 90% for Ca, Ce, Sm, and V,

89 afety of Gd-lip containing PE-DTPA chelating Gd(+3) prepared by lipid film hydration method.

90 water-soluble, narrow-line Gd(III) complex, [Gd(tpatcn)], doubling the magic-angle-spinning DNP enhan

91 Liposomes with Gd-complexes (Gd-lip) co-encapsulated with thrombolytic agents can ser

92 earth:transition-metal films of composition Gd(x)Co(100-x), Gd(x)Fe(100-x) and Gd(x)(Co(50)Fe(50))(1

93 d T1 contrast in MR imaging by concentrating Gd(III) within the nanoparticle.

94 t IgG by routine immunofluorescence, contain Gd-IgA1-specific IgG autoantibodies.

95 mations in the brain on Gadolinium-contrast (Gd-C) T1w-MRI, and their impact on survival.

96 soflurane and infused paramagnetic contrast (Gd-DOTA) into the cisterna magna during dynamic contrast

97 In contrast, Gd-P showed lower capability of inhibition of linoleic a

98 4.7 T, substantially surpassing conventional Gd(III) chelating agents (r1 approximately 3 mM(-1)s(-1)

99 ere stronger J(Gd-rad) for the corresponding Gd(3+) compounds is associated with larger thermal barri

100 l nanoagent based on Merocyanine 540-coupled Gd(2) (WO(4) )(3) :Tb nanoscintillators and the vitaliza

101 A1 glycoforms with some galactose-deficient (Gd) HR O-glycans play a key role in IgAN pathogenesis.

102 ( Av) and Gluconacetobacter diazotrophicus ( Gd), have established that the P-cluster is conformation

103 d contrast agent, gadopentetate dimeglumine (Gd(DTPA)(2-)), was used as the imageable cargo.

104 ate (Mn-PyC3A) to gadopentetate dimeglumine (Gd-DTPA) and to evaluate the excretion, pharmacokinetics

105 umerous drugs including gadoxetate disodium (Gd-EOB-DTPA).

106 porous silica could also capture dissociated Gd and other GBCAs.

107 CP1 has three distinct components: a DOTA-Gd(III) chelate that provides the MR signal enhancement,

108 parameters to the 4f states of encapsulated Gd atoms are discussed.

109 The encapsulated Gd atom forms a charged centre that sets up two single-e

110 ][6,6]-addition sites and with an endohedral Gd(3)N cluster that is completely flattened.

111 enlarging T2 lesions, gadolinium-enhancing (Gd+) T1 lesions, new T1 hypointense lesions and combined

112 ants with no change in gadolinium-enhancing [Gd+] lesion number with opicinumab vs 27 [79%] of 34 wit

113 trations of 10 REEs (La, Ce, Pr, Nd, Sm, Eu, Gd, Dy, Er, Yb) in ppb levels.

114 sing Rare Earths (Y, La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu) and trace elements (Li,

115 in the E4 loop near the TRPC5 extracellular Gd(3+) binding site, is critical for conferring the sens

116 witching of a nearly compensated ferrimagnet Gd(x) (FeCo)(1-) (x) by the topological insulator [Bi(2)

117 Ferromagnetic Gd(5)Si(4) particles were formulated in terpineol oil an

118 AEs through a transition from ferromagnetic [Gd(2)C](2+).2e(-) to antiferromagnetic Gd(2)CCl caused b

119 e use two Li(+) -insulating oxides (fluorite Gd(0.1) Ce(0.9) O(1.95) and perovskite La(0.8) Sr(0.2) G

120 ts (e.g., 24% for Zn, 50% for P, and 83% for Gd), indicating large anthropogenic inputs via the waste

121 derate to excellent (k range, 0.56-0.86) for Gd-EOB MRI and substantial to excellent for MDCT (k rang

122 The transfer coefficient Ktrans for Gd-DTPA and the drug concentrations showed a good linear

123 for cancer theranostics and perspectives for Gd nanomaterial-based cancer theranostics are provided.

124 tion and unprecedented metal selectivity for Gd(3+) over physiological metal ions with strong transla

125 fluorescence microscopy had IgG specific for Gd-IgA1.

126 modeling was used to design a series of four Gd complexes capable of forming an intramolecular H-bond

127 he cell with the 3D textile anode framework, Gd:CeO2 -Li/Na2 CO3 composite electrolyte, and Sm0.5 Sr0

128 The most frequent Gd site was T(236), followed by S(230), T(233), T(228),

129 t; the phosphate is completely released from Gd-TREN-MAM below pH 2.

130 g peak (SOBP) centered on an 8 cm(3), 3 mg/g Gd infused tumor.

131 lements (Ag, As, Ce, Co, Cs, Cu, Eu, Fe, Ga, Gd, La, Lu, Mn, Mo, Nb, Nd, Ni, Pr, Rb, Sm, Te, Ti, Tl,

132 s study: (Case 1) a composite BP: gadolinia (Gd(2)O(3)) or erbia (Er(2)O(3)) with 150 mum thickness Z

133 Gadolinium (Gd) has been detected in the brain, bone and skin of pat

134 Gadolinium (Gd)-based contrast agents are extensively used for magne

135 rom thermal neutron capture in a gadolinium (Gd) infused tumor as a result of secondary neutrons from

136 selective cation channel blocker Gadolinium (Gd(3+)).

137 In GBCAs gadolinium (Gd) is present in a bound chelated form.

138 Herein, gadolinium (Gd)-rose bengal coordination polymer nanodots (GRDs) are

139 a-targeted liposomal macrocyclic gadolinium (Gd) imaging agent, for MRI of amyloid plaques.

140 However, most gadolinium (Gd)-chelator MR contrast agents are limited by their rel

141 In this regard, several types of gadolinium (Gd)-based nanomaterials have been introduced to combine

142 ed highly effective for removing gadolinium (Gd) from the body.

143 MR) contrast agent with a single gadolinium (Gd) chelate using a quantitative MRI T1 mapping techniqu

144 d tomography (CT) enabled by the gadolinium (Gd) element contained in the UCNP.

145 ble condition recently linked to gadolinium (Gd) exposure during MRI with contrast.

146 e presence or absence of visible gadolinium (Gd) leakage.

147 earance of the hepatobiliary-specific GBCAs, Gd-EOB-DTPA, and gadobenate dimeglumine, primarily thoug

148 to-single-crystal transformation to generate Gd-IHEP-8.

149 Cell viability tests of HAp:Gd/Yb/Tm and HAp:Gd/Eu powders in human dental pulp stem cell cultures in

150 "-conversion spectra of HAp:Gd/Yb/Tm and HAp:Gd/Eu powders showed characteristic transitions of Tm(3+

151 Cell viability tests of HAp:Gd/Yb/Tm and HAp:Gd/Eu powders in human dental pulp stem

152 p"- and the "down"-conversion spectra of HAp:Gd/Yb/Tm and HAp:Gd/Eu powders showed characteristic tra

153 dynamic contrast enhanced imaging using HSA-Gd(III)DTPA.

154 es of IgG bound to galactose-deficient IgA1 (Gd-IgA1).

155 Er(III), La(III), Yb(III), Eu(III), Pr(III), Gd(III), Lu(III), Dy(III), Tb(III), Ho, and Ru(III).

156 umor enhancement and a sustained increase in Gd concentration in both heterotopic and orthotopic tumo

157 ster environment was converted to the one in Gd MoFeP (betaPhe99Tyr/betaSer188Ala), and (3) two oxyge

158 d switching between two electronic states in Gd@C(82).

159 across IAEs, inducing the ferromagnetism in [Gd(2)C](2+).2e(-) electride.

160 With increasing Gd content the film structure transitions from crystalli

161 aging tools due to incorporation of Gd ions, Gd chelates and Gd/other imaging probes in the theranost

162 s the magnetic exchange coupling constant, J(Gd-rad), for the gadolinium compounds in this series to

163 for 1-Dy through 4-Dy and the magnitude of J(Gd-rad) for the corresponding gadolinium derivatives tha

164 magnets 1-Dy through 4-Dy, where stronger J(Gd-rad) for the corresponding Gd(3+) compounds is associ

165 odating the Gd atoms of the relatively large Gd(3)N cluster inner space at the sp(3) addition sites.

166 eams resulted in 10, 17 and 1.3 times larger Gd neutron captures per GyE than protons, respectively.

167 tion of a stable, water-soluble, narrow-line Gd(III) complex, [Gd(tpatcn)], doubling the magic-angle-

168 p*(2)Ln)(2)(mu-5,5'-R(2)bpym)](BPh(4)) (Ln = Gd, Dy; R = NMe(2) (1), OEt (2), Me (3), F (4); bpym = 2

169 olated [Ln(Cp(ttt))2](+) cations (1-Ln; Ln = Gd, Ho, Er, Tm, Yb, Lu), synthesized by halide abstracti

170 bstraction of [Ln(Cp(ttt))2(Cl)] (2-Ln; Ln = Gd, Ho, Er, Tm, Yb, Lu).

171 eterometallic wheel complexes {Cr8 Ln8 } (Ln=Gd, Dy and Y) with alternating metal centres are present

172 3 -HAN) (Cp*=pentamethylcyclopentadienyl; Ln=Gd, Tb, Dy; HAN=hexaazatrinaphthylene) proceeds through

173 helical pitch as small as 2.8 nm in metallic Gd(3)Ru(4)Al(12), which materializes a breathing kagome

174 rated high sensitivity at 0.20 and 0.15 mmol Gd/kg and excellent specificity at all dose levels for i

175 -001 was tested at 0.10, 0.15, and 0.20 mmol Gd/kg.

176 in rats and monkeys at doses up to 0.30 mmol Gd/kg.

177 cumulation kinetics than the small molecule, Gd-DTPA.

178 Moreover, Gd-lip did not show pro-inflammatory effects, as assesse

179 epentaacetate gadolinium, referred to as MPO-Gd, and cross-linked iron oxide nanoparticle (CLIO-NP) i

180 s 1.02 [95% CI: 0.89, 1.14]; P = .03) at MPO-Gd MR imaging.

181 Conclusion MPO-Gd showed elevated MPO activity in NAFLD mouse models an

182 t MRI at 9.4 T and received gadodiamide, MPO-Gd, or CLIO-NPs.

183 with MPO-Gd, which proves specificity of MPO-Gd.

184 Results MPO-Gd enhancement occurred in inflammatory CM hotspots (olf

185 ven human liver biopsy samples underwent MPO-Gd-enhanced MR imaging ex vivo and subsequent histologic

186 Purpose To test whether MPO-Gd, an activatable molecular magnetic resonance (MR) ima

187 umine and in MPO knockout NASH mice with MPO-Gd, which proves specificity of MPO-Gd.

188 ental NASH and underwent MR imaging with MPO-Gd.

189 cles (MSNs) producing gadolinium-loaded MSN (Gd-MSN).

190 group and 0.85 for the opicinumab group] new Gd+ lesions per participant in both groups).

191 d peripheral nervous tissues (1.8-333.2 nmol Gd/g tissue).

192 e TRPC5R593A mutant, whereas the addition of Gd(3+) rescues the mutant's sensitivity to GPCR-Gq/11-PL

193 results showing that the minor-bis-adduct of Gd(3)N@I(h)-C(80) isomerized to the major-adduct, a poss

194 ments of pristine, bis-, and tris-adducts of Gd(3)N@C(80) suggested that the rotation of the endohedr

195 A positive correlation between the amount of Gd(DTPA)(2-) released and T(1) was found.

196 The amount of Gd(DTPA)(2-) released was controlled by HIFU stimulation

197 lycoforms enabled quantitative assignment of Gd sites.

198 ered electron imaging) allowed assignment of Gd structures to the histological bone structures.

199 knock-off mechanism, while tight binding of Gd(3+) to the aspartate ring blocks the channel and prev

200 We detected no cytotoxicity of Gd-lip in human liver cells including cancer HepG2, prog

201 efficient uptake and uniform distribution of Gd-MSN.

202 d mice, glymphatic transport and drainage of Gd-DOTA to submandibular and deep cervical lymph nodes w

203 a T1 mapping which also captures drainage of Gd-DOTA to the cervical lymph nodes.

204 Furthermore, no potential side effects of Gd-lip were found using a complex system including gener

205 The enhanced catalytic efficiency of Gd-IHEP-8 versus Gd-IHEP-7 is attributed to intermediate

206 For the structural elucidation of Gd(3)N@I(h)-C(80) tris- and tetra-adducts, density funct

207 Furthermore, MRI-based estimates of Gd-DTPA transport across these barriers might be useful

208 ctures of two bis-ethylpyrrolidinoadducts of Gd(3)N@I(h)-C(80), obtained by regioselective 1,3-dipola

209 ronic structure and spin flip excitations of Gd 4f electrons.

210 These ZES-SPIONs are free of Gd and show a high T1 contrast power.

211 magnetic reversal behaviour as a function of Gd content is strongly dependent on the transition metal

212 ed via imaging tools due to incorporation of Gd ions, Gd chelates and Gd/other imaging probes in the

213 Measurements of Gd-NM revealed a strongly enhanced T1 relaxivity (r1 app

214 By tuning the net magnetic moment of Gd(x) (FeCo)(1-) (x) via changing the composition, the S

215 In this study, we evaluated nanosafety of Gd-lip containing PE-DTPA chelating Gd(+3) prepared by l

216 rging T2 lesions (52.6%, p<0.001), number of Gd+ T1 lesions per scan (66.0%, p<0.001), annualised rat

217 only, whereas the signal-to-noise ratios of Gd, Er, and Yb were further improved by increasing the m

218 We observed ventricular reflux of Gd-DOTA in SHR rats only, indicating abnormal CSF flow d

219 rotational motion and increase relaxivity of Gd complexes.

220 14.06 mM(-1) s(-1) ), low risk of release of Gd ions, and NIR-triggered drug release.

221 ting capabilities of MRgHIFU, the release of Gd(DTPA)(2-) stimulated by HIFU was pinpointed at the HI

222 ntent that facilitates whole body removal of Gd using a hemoperfusion system consisting of a cartridg

223 study indicates potential in vivo safety of Gd-lip with respect to hepatotoxicity and immunopatholog

224 However, the underlying key energy scales of Gd x Sc3-x N@C80 (x = 1-3) remain unclear.

225 the first example of a crystal structure of Gd(3)N@I(h)-C(80) derivatives.

226 hemoperfusion of aqueous toxins, in terms of Gd capture capacity and rate.

227 sis revealed impeded glymphatic transport of Gd-DOTA in SHR compared with WKY rats in both age groups

228 o verified increased glymphatic transport of Gd-DOTA transport in mice anesthetized with KX in compar

229 ris(carbonyl))tris(4-ox o-4H-pyran-3-olate) (Gd-TREN-MAM).

230 astic x-ray scattering (RIXS) experiments on Gd x Sc3-x N@C80 at Gd N 4,5-edges to directly study the

231 n at the Ce site in CeRhIn5, either by Nd or Gd, induces a zero-field magnetic instability inside the

232 A using phospholipase A2 receptor (PLA2R) or Gd-IgA1 as antigen.

233 us muscle at 9 seconds following Mn-PyC3A or Gd-DTPA injection.

234 perse nanohelices based on gadolinium oxide (Gd(2)O(3)).

235 In water at neutral pH, Gd-TREN-MAM binds phosphate with high affinity (Ka = 1.3

236 of fibrosis, whereas the fibrogenesis probe Gd-Hyd proved most accurate for detecting treatment resp

237 533 and allysine-targeted fibrogenesis probe Gd-Hyd, MR elastography, and native T1 to characterize f

238 are warmed above -15 degrees C, they reform Gd(II) complexes.

239 ely low relaxivity and high risk of released-Gd-ions-associated toxicity.

240 le peptide DEVD is cleaved and the remaining Gd(III)-AIEgen (Gad-AIE) conjugate aggregates leading to

241 ,2-HOPO-Davisil hemoperfusion system removed Gd by 3.4 times over the Gambro AC system.

242 al-containing metal-organic framework (RMOF) Gd-IHEP-7, which upon heating in air undergoes a single-

243 spectively, and one soluble protein samples (Gd-P) in a pilot scale from glanded cottonseed meal.

244 on based spectroscopic imaging and secondary Gd dose enhancement could be viable and likely beneficia

245 Ablation after TSL injection showed [Gd(HPDO3A)(H2O)] and dox release along the tumor rim, mi

246 molecular contrast agent containing a single Gd ion showed significant tumor enhancement and a sustai

247 l family of f-element compounds (Ce, Nd, Sm, Gd; Am, Bk, Cf) of the redox-active dioxophenoxazine lig

248 the spatial confinement of the T(1) source (Gd(3+) ions) leads to an "OFF" MRI signal due to insuffi

249 we report that the IAEs in layer structured [Gd(2)C](2+).2e(-) electride behave as ferromagnetic elem

250 rs a new route to designing and synthesizing Gd-based nanotheranostics for image-guided cancer therap

251 1, 1.00) for EP-3533, followed by native T1, Gd-Hyd, and MR elastography with AUCs of 0.90 (95% CI: 0

252 alyzed systematically (T1w, T2w, T2*w, T1w + Gd, and DWI), in order to discern a specific pattern of

253 or more than 1 h, about 10 times longer than Gd-based CAs currently used in clinic.

254 We show that Gd and their analogous Y complexes have similar properti

255 Initial rodent imaging studies showed that Gd(1) remains in the vascular system much longer than an

256 The Gd-DOTA injection into CSF was performed on the bench af

257 cage, which is favored for accommodating the Gd atoms of the relatively large Gd(3)N cluster inner sp

258 cal structures were measured by aligning the Gd-C T1w-MRI to a healthy atlas.

259 rical dipole orientations generated from the Gd atom being trapped at two different sites inside the

260 view aims to overview recent advances in the Gd-based nanomaterials for cancer theranostics and persp

261 er molecular mass bands were observed in the Gd-P gel image.

262 that can be used to produce an image of the Gd enriched tumor.

263 reaction driven by the strain release of the Gd(3)N@C(80) fullerene structure.

264 Exposure of the Gd-MSN containing tumor spheroids to monochromatic X-ray

265 er gadobutrol administration showed that the Gd persisted for at least 54 minutes and was completely

266 inker to saturate ligand coordination to the Gd(III) ion.

267 ay Equivalent dose (GyE) occurred within the Gd tumor region.

268 have been developed and utilized, among them Gd(III)-chelates which offer high sensitivity at high ma

269 using submicro-SR-XRF allowed resolving thin Gd structures in cortical bone, as well as correlating t

270 cted; nine glycopeptides carried up to three Gd O-glycans.

271 nd of gadolinium metallofullerene with three Gd ions in one carbon cage, acts as a satellite anchorin

272 MRI facilitated visualization of thrombin + Gd solution transiting through cerebral vasculature and

273 y excretion with similar pharmacokinetics to Gd-DTPA (area under the curve between 0 and 30 minutes,

274 Toxicity concerns related to Gd(III)-based magnetic resonance imaging (MRI) agents pr

275 y by modulating the coordination of water to Gd(III) .

276 Moreover, TP-Gd/miRNA-ColIV also demonstrates good magnetic resonance

277 rt a multifunctional delivery nanosystem (TP-Gd/miRNA-ColIV) composed of gadolinium-chelated tannic a

278 After the treatment with TP-Gd/miR-145-ColIV, nearly no dissection occurs in the tho

279 MR visible tracer (Gd-albumin) was infused in vivo into the CSF-filled late

280 or before ablation ensured homogeneous TSL, [Gd(HPDO3A)(H2O)], and dox delivery across the tumor.

281 Mean tumor Gd and Dy concentration measurements from both single ag

282 proven mCRC (512 liver metastases) underwent Gd-EOB MRI and MDCT imaging.

283 post-injection than does a commercially used Gd(III) agent and also produces similar T(1) relaxivity

284 ced catalytic efficiency of Gd-IHEP-8 versus Gd-IHEP-7 is attributed to intermediates stabilized by e

285 When Gd-MSN was added to the tumor spheroids, we observed eff

286 While Gd-P showed the highest activities, Gl-L and Gd-L exhibi

287 With Gd doping the anomalous Hall resistivity of Co, Fe and C

288 to combine different therapeutic agents with Gd to enhance the efficacy of therapeutic agents.

289 n of the Ca(2+) sensing receptor (CaSR) with Gd(3+) triggers the appearance of ZO-2 at the cell borde

290 d that Fe(III) complexes cannot compete with Gd(III) complexes as T(1) MRI contrast agents.

291 Following complexation with Gd, this PTPmu-targeted molecular contrast agent contain

292 Liposomes with Gd-complexes (Gd-lip) co-encapsulated with thrombolytic

293 but not MN or LN immunodeposits reacted with Gd-IgA1.

294 aders had higher diagnostic sensitivity with Gd-EOB MRI than with MDCT (95.5% vs. 72% reader 1; 90% v

295 Sites with Gd O-glycans were unambiguously identified by electron-t

296 GdCoFe shows a similar trend with Gd doping for the in-plane reversal field to that of GdF

297 increases by less than a factor of two with Gd doping of 11%, while for Fe, the coercivity falls by

298 ists of beta-NaYbF(4) (core) @NaY(0.8-x)Er(x)Gd(0.2)F(4) (interior shell) @NaY(0.8)Gd(0.2)F(4) (exter

299 n-metal films of composition Gd(x)Co(100-x), Gd(x)Fe(100-x) and Gd(x)(Co(50)Fe(50))(100-x) were prepa

300 with REBCO (REBa(2)Cu(3)O(x), where RE = Y, Gd) on a 30-micrometre-thick substrate(3), making the co